日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Intravenous Tocilizumab versus Standard of Care in the Treatment of Severe and Critical COVID-19-related Pneumonia: A Single-center, Double-blind, Placebo-controlled, Phase 3 Trial

静脉注射托珠单抗与标准疗法治疗重症和危重症 COVID-19 相关肺炎:一项单中心、双盲、安慰剂对照的 3 期试验

Amante, Eric Jason B; David-Wang, Aileen S; Tee, Michael L; Punzalan, Felix Eduardo R; Añonuevo, John C; Fernandez, Lenora C; Albay, Albert B Jr; Malabad, John Carlo M; Climacosa, Fresthel Monica M; Pajes, A Nico Nahar I; Cuaño, Patricia Maria Gregoria M; Alejandría, Marissa M

Efficacy and Safety of Subcutaneous Golimumab in Methotrexate-Naive Patients With Rheumatoid Arthritis: Five-Year Results of a Randomized Clinical Trial

皮下注射戈利木单抗治疗未接受过甲氨蝶呤治疗的类风湿性关节炎患者的疗效和安全性:一项随机临床试验的五年结果

Emery, Paul; Fleischmann, Roy M; Strusberg, Ingrid; Durez, Patrick; Nash, Peter; Amante, Eric Jason B; Churchill, Melvin; Park, Won; Pons-Estel, Bernardo; Han, Chenglong; Gathany, Timothy A; Xu, Stephen; Zhou, Yiying; Leu, Jocelyn H; Hsia, Elizabeth C